Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Cancer Clinical Trials|January 1, 1981
Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomasN E Mischler, D C Tormey, J Klotz, et al.
Journal of Interferon Research|December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomasE C Borden, K Kim, L Ryan, et al.
Cancer|August 1, 1975
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancerT P Waalkes, C W Gehrke, R W Zumwalt, et al.
Cancer Treatment Reports|July 1, 1985
Phase I study of vinblastine and verapamil given by concurrent iv infusionA B Benson, D L Trump, J M Koeller, et al.
Cancer|March 15, 1997
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology GroupJ E Olson, D Neuberg, K J Pandya, et al.
Cancer|December 1, 1975
An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristineD L Ahmann, H F Bisel, R G Hahn, et al.
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase II study of goserelin for patients with postmenopausal metastatic breast cancerT Saphner, A B Troxel, D C Tormey, et al.
Human Pathology|September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerD C Allred, G M Clark, R Molina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology GroupP D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Cancer Clinical Trials|January 1, 1981
Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomasN E Mischler, D C Tormey, J Klotz, et al.
Journal of Interferon Research|December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomasE C Borden, K Kim, L Ryan, et al.
Cancer|August 1, 1975
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancerT P Waalkes, C W Gehrke, R W Zumwalt, et al.
Cancer Treatment Reports|July 1, 1985
Phase I study of vinblastine and verapamil given by concurrent iv infusionA B Benson, D L Trump, J M Koeller, et al.
Cancer|March 15, 1997
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology GroupJ E Olson, D Neuberg, K J Pandya, et al.
Cancer|December 1, 1975
An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristineD L Ahmann, H F Bisel, R G Hahn, et al.
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase II study of goserelin for patients with postmenopausal metastatic breast cancerT Saphner, A B Troxel, D C Tormey, et al.
Human Pathology|September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerD C Allred, G M Clark, R Molina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology GroupP D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.
Pageof 14